Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00905242 · ClinicalTrials.gov registry record · Phase 4
Impact of Myfortic on Gastrointestinal (GI) Prophylaxis in Maintenance Renal Transplant Patients
A Phase 4 study, sponsored by East Carolina University.
- Completed
- Registry status
- Phase 4
- Development phase
- 61
- Enrollment target
NCT00905242 is a Phase 4 study that has completed, run by East Carolina University. The registered enrollment target is 61 participants.
The verdict
NCT00905242, a Phase 4 study, has completed, sponsored by East Carolina University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 61 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether maintenance renal transplant patients receiving Myfortic can reduce or discontinue GI prophylaxis medications.
Interventions
- DRUG GI medication
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2006-03 |
| Est. Completion | 2007-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00905242
The ClinicalTrials.gov registry entry for NCT00905242 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is East Carolina University, which has 58 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GI medication is the first listed.
NCT00905242 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00905242 about?
NCT00905242 is a clinical study titled "Impact of Myfortic on Gastrointestinal (GI) Prophylaxis in Maintenance Renal Transplant Patients". The purpose of this study is to determine whether maintenance renal transplant patients receiving Myfortic can reduce or discontinue GI prophylaxis medications.
What is the current status of trial NCT00905242?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 61 participants. The study started on 2006-03. Estimated completion is 2007-01.
What interventions are being tested in trial NCT00905242?
The interventions under investigation include: GI medication (DRUG).
Who is sponsoring clinical trial NCT00905242?
This trial is sponsored by East Carolina University, which has 58 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.